ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

NCI Gets 41.258 Bil. In Final FY 1986 Appropriations

November 29, 1985

In Brief: Abeloff Directs John Hopkins Oncology Center; Claudia Baquet Named Deputy Secretary In HHS

September 25, 1992

BMT Ok For some Stage IV Breast Cancer, Blues Advisor Say

March 8, 1996